SCHEMBL1044584

SCHEMBL1044584

CCCCCCCCCCCCCCCC(=O)OCCN1CCN(CCO)C1CCCCCCCCCCCCCCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.50
DNM1 Q05193 1/20 0.43
PRKCA P17252 3/20 0.40
PAM P19021 2/20 0.40
KDM4E B2RXH2 1/20 0.40
DUSP3 P51452 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
LMNA P02545 1/20 0.40
MGLL Q99685 1/20 0.39
PRSS1 P07477 1/20 0.39
PRSS2 P07478 1/20 0.39
PRSS3 P35030 1/20 0.39
TSHR P16473 1/20 0.38
MAPT P10636 1/20 0.38
EPHX2 P34913 1/20 0.38
PRKCE Q02156 1/20 0.38
PRKCQ Q04759 1/20 0.38
PRKCD Q05655 1/20 0.38
USP2 O75604 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL888281 0.99 DGKA (0.49) DGKADNM1PRKCAPAMKDM4E
Hydrochloric Acid SCHEMBL18209372 0.99 DGKA (0.49) DGKADNM1PRKCAPAMKDM4E
SCHEMBL441411 0.93 MGLL (0.51) DGKAPRKCAMGLLMAPTEPHX2
SCHEMBL747314 0.93 MGLL (0.51) DGKAPRKCAMGLLMAPTEPHX2
Hydrochloric Acid SCHEMBL1047267 0.92 MGLL (0.50) DGKAPRKCAMGLLMAPTEPHX2
Hydrochloric Acid SCHEMBL421821 0.92 MGLL (0.50) DGKAPRKCAMGLLMAPTEPHX2
Water SCHEMBL6549699 0.92 MGLL (0.50) DGKAPRKCAMGLLMAPTEPHX2
SCHEMBL22400859 0.88 DGKA (0.51) DGKADNM1PRKCAPAMKDM4E
Hydrochloric Acid SCHEMBL21328518 0.87 DGKA (0.50) DGKADNM1PRKCAPAMLMNA
Hydrochloric Acid SCHEMBL21293922 0.87 DGKA (0.50) DGKADNM1PRKCAPAMLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3397244-B1 TREATMENT OF BREAST CANCER USING A COMBINATION OF A CATIONIC LIPOSOMAL FORMULATION OF TAXANE, A NON-LIPOSOMAL FORMULATION OF TAXANE AND A FURTHER ACTIVE AGENT SYNCORE BIOTECHNOLOGY CO LTD (TW) 2021-10-06 EP claimed
EP-3939572-B1 VEHICLES FOR CONTROLLED DELIVERY OF DIFFERENT PHARMACEUTICAL AGENTS UNIV YALE (US) 2024-03-27 EP disclosed
EP-3520780-B1 VEHICLES FOR CONTROLLED DELIVERY OF DIFFERENT PHARMACEUTICAL AGENTS UNIV YALE (US) 2023-07-26 EP disclosed
EP-3939572-A1 VEHICLES FOR CONTROLLED DELIVERY OF DIFFERENT PHARMACEUTICAL AGENTS Yale University, Inc. (US) 2022-01-19 EP disclosed
EP-3520780-A1 VEHICLES FOR CONTROLLED DELIVERY OF DIFFERENT PHARMACEUTICAL AGENTS Yale University (US) 2019-08-07 EP disclosed
EP-2836234-B1 VEHICLES FOR CONTROLLED DELIVERY OF DIFFERENT PHARMACEUTICAL AGENTS UNIV YALE (US) 2019-06-12 EP disclosed
EP-2286795-A1 Method of producing a cationic liposomal preparation comprising a lipophilic compound MediGene AG (DE) 2011-02-23 EP disclosed
EP-2277507-A1 Method of producing a cationic liposomal preparation comprising a lipophilic compound MediGene AG (DE) 2011-01-26 EP disclosed
EP-2200637-A2 LONG INTERSPERSED NUCLEAR ELEMENT POLYPEPTIDE COMPOSITIONS AND METHODS OF USE THEREOF The J. David Gladstone Institutes (US) 2010-06-30 EP disclosed
EP-2108362-A2 Method of producing a cationic liposomal preparation comprising a lipophilic compound Medigene AG (DE) 2009-10-14 EP disclosed
EP-1530465-B1 METHOD OF PRODUCING A CATIONIC LIPOSOMAL PREPARATION COMPRISING A LIPOPHILIC COMPOUND MEDIGENE AG (DE) 2009-09-30 EP disclosed
WO-2009038756-A2 LONG INTERSPERSED NUCLEAR ELEMENT POLYPEPTIDE COMPOSITIONS AND METHODS OF USE THEREOF THE J. DAVID GLADSTONE INSTITUTES (US) 2009-03-26 WO disclosed
EP-1767192-A2 Cationic lipid compositions targeting angiogenic endothelial cells The Regents of the University of California (US) 2007-03-28 EP disclosed
EP-1014945-A1 CATIONIC LIPID COMPOSITIONS TARGETING ANGIOGENIC ENDOTHELIAL CELLS The Regents of the University of California (US) 2000-07-05 EP disclosed
WO-1998040052-A9 CATIONIC LIPID COMPOSITIONS TARGETING ANGIOGENIC ENDOTHELIAL CELLS UNIV CALIFORNIA (US) 1999-09-02 WO disclosed
WO-1998040052-A1 CATIONIC LIPID COMPOSITIONS TARGETING ANGIOGENIC ENDOTHELIAL CELLS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-09-17 WO disclosed